Experience of complex application of cardiac contractility modulation by Optimizer Smart System and endovascular mitral valve repair by the MitraClip System in the treatment of heart failure

A 58-year-old female patient with severe chronic heart failure and mitral regurgitation receiving an optimal drug therapy was implanted with an Optimizer Smart device for modulation of cardiac contractility and underwent transcatheter mitral plasty using a MitraClip system. The complex therapy resulted in a significant clinical improvement and beneficial dynamics of echocardiographic parameters.

1.

2. Braunwald’s heart disease: a textbook of cardiovascular medicine. 2-Volume Set 11th Edition. Zipes DP, Libby P, Bonow RO, Mann DL, Tomaselli GF, Braunwald E, editors -Philadelphia, PA: Elsevier;2019. - 1944 p. ISBN 978-0-323-46342-3

3. Seferovic PM, Ponikowski P, Anker SD, Bauersachs J, Chioncel O, Cleland JGF et al. Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure. 2019;21(10):1169–86. DOI: 10.1002/ejhf.1531

4. Komajda M, Cowie MR, Tavazzi L, Ponikowski P, Anker SD, Filippatos GS et al. Physicians’ guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry. European Journal of Heart Failure. 2017;19(11):1414–23. DOI: 10.1002/ejhf.887

5. Tereshchenko S.N., Romanova N.V., Zhirov I.V., Osmolovskaya Yu.F., Golitsyn S.P. Russian Registry of Patients with Chronic Heart Failure and Atrial Fibrillation (RIF-CHF): Clinical and demographic characteristics of the sample upon inclusion into the Registry. Russian Heart Failure Journal. 2016;17(6):418–26. DOI: 10.18087/rhfj.2016.6.2276

6. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology. 2013;62(16):e147-239. DOI: 10.1016/j.jacc.2013.05.019

7. Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP et al. Heart Disease and Stroke Statistics–2020 Update: A Report From the American Heart Association. Circulation. 2020;141(9):e139–596. DOI: 10.1161/CIR.0000000000000757

8. Maddox TM, Januzzi JL, Allen LA, Breathett K, Butler J, Davis LL et al. 2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction. A Report of the American College of Cardiology Solution Set Oversight Committee. Journal of the American College of Cardiology. 2021;77(6):772–810. DOI: 10.1016/j.jacc.2020.11.022

9. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal. 2016;37(27):2129–200. DOI: 10.1093/eurheartj/ehw128

10. Tereshchenko S.N., Galyavich A.S., Uskach T.M., Ageev F.T., Arutyunov G.P., Begrambekova Yu.L. et al. 2020 Clinical practice guidelines for Chronic heart failure. Russian Journal of Cardiology. 2020;25(11):311–74. DOI: 10.15829/1560-4071-2020-4083

11. Steffel J, Robertson M, Singh JP, Abraham WT, Bax JJ, Borer JS et al. The effect of QRS duration on cardiac resynchronization therapy in patients with a narrow QRS complex: a subgroup analysis of the EchoCRT trial. European Heart Journal. 2015;36(30):1983–9. DOI: 10.1093/eurheartj/ehv242

12. Borggrefe M, Mann DL. Cardiac Contractility Modulation in 2018. Circulation. 2018;138(24):2738–40. DOI: 10.1161/CIRCULATIONAHA.118.036460

13. Salukhe TV, Henein MY, Sutton R. Ischemic Mitral Regurgitation and Its Related Risk After Myocardial Infarction. Circulation. 2005;111(3):254–6. DOI: 10.1161/01.CIR.0000154574.46566.D5

14. Grigioni F, Detaint D, Avierinos J-F, Scott C, Tajik J, Enriquez-Sarano M. Contribution of ischemic mitral regurgitation to congestive heart failure after myocardial infarction. Journal of the American College of Cardiology. 2005;45(2):260–7. DOI: 10.1016/j.jacc.2004.10.030

15. Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. European Heart Journal. 2017;38(36):2739–91. DOI: 10.1093/eurheartj/ehx391

16. Saidova M.A., Andrianova A.M. Ischemic Mitral Regurgitation: Echocardiographic Algorithm, the Place of Three-Dimensional Transesophageal Echocardiography. Kardiologiia. 2020;60(2):54–60. DOI: 10.18087/cardio.2020.2.n839

17. Asch FM, Grayburn PA, Siegel RJ, Kar S, Lim DS, Zaroff JG et al. Echocardiographic Outcomes After Transcatheter Leaflet Approximation in Patients with Secondary Mitral Regurgitation: The COAPT Trial. Journal of the American College of Cardiology. 2019;74(24):2969–79. DOI: 10.1016/j.jacc.2019.09.017

18. Giustino G, Lindenfeld J, Abraham WT, Kar S, Lim DS, Grayburn PA et al. NYHA Functional Classification and Outcomes After Transcatheter Mitral Valve Repair in Heart Failure: The COAPT Trial. JACC: Cardiovascular Interventions. 2020;13(20):2317–28. DOI: 10.1016/j.jcin.2020.06.058

19. Setoguchi S, Stevenson LW, Schneeweiss S. Repeated hospitalizations predict mortality in the community population with heart failure. American Heart Journal. 2007;154(2):260–6. DOI: 10.1016/j.ahj.2007.01.041

20. Rogers JK, Pocock SJ, McMurray JJV, Granger CB, Michelson EL, Östergren J et al. Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved. European Journal of Heart Failure. 2014;16(1):33–40. DOI: 10.1002/ejhf.29

21. York MK, Gupta DK, Reynolds CF, Farber-Eger E, Wells QS, Bachmann KN et al. B-Type Natriuretic Peptide Levels and Mortality in Patients with and Without Heart Failure. Journal of the American College of Cardiology. 2018;71(19):2079–88. DOI: 10.1016/j.jacc.2018.02.071

22. Porapakkham P. B-Type Natriuretic Peptide–Guided Heart Failure Therapy: A Meta-analysis. Archives of Internal Medicine. 2010;170(6):507–14. DOI: 10.1001/archinternmed.2010.35

23. Borggrefe MM, Lawo T, Butter C, Schmidinger H, Lunati M, Pieske B et al. Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure. European Heart Journal. 2008;29(8):1019–28. DOI: 10.1093/eurheartj/ehn020

24. Abraham WT, Kuck K-H, Goldsmith RL, Lindenfeld J, Reddy VY, Carson PE et al. A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation. JACC: Heart Failure. 2018;6(10):874–83. DOI: 10.1016/j.jchf.2018.04.010

25. Giallauria F, Vigorito C, Piepoli MF, Stewart Coats AJ. Effects of cardiac contractility modulation by non-excitatory electrical stimulation onexercise capacity and quality of life: An individual patient’s data metaanalysis of randomized controlled trials. International Journal of Cardiology. 2014;175(2):352–7. DOI: 10.1016/j.ijcard.2014.06.005

26. Wiegn P, Chan R, Jost C, Saville BR, Parise H, Prutchi D et al. Safety, Performance, and Efficacy of Cardiac Contractility Modulation Delivered by the 2-Lead Optimizer Smart System: The FIX-HF5C2 Study. Circulation: Heart Failure. 2020;13(4):e006512. DOI: 10.1161/CIRCHEARTFAILURE.119.006512

27. Silbiger JJ. Novel Pathogenetic Mechanisms and Structural Adaptations in Ischemic Mitral Regurgitation. Journal of the American Society of Echocardiography. 2013;26(10):1107–17. DOI: 10.1016/j.echo.2013.07.003

28. Piérard LA, Lancellotti P. The Role of Ischemic Mitral Regurgitation in the Pathogenesis of Acute Pulmonary Edema. New England Journal of Medicine. 2004;351(16):1627–34. DOI: 10.1056/NEJMoa040532

29. Imaev T.E., Komlev A.E., Kuchin I.V., Akchurin R.S. Transcatheter methods of treatment of mitral valve pathology: current state of the problem. Part 1. Russian Cardiology Bulletin. 2020;15(1):4–13. DOI: 10.36396/MS.2020.16.1.001